VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart DownInvestorPlace • 12/01/21
Stanford Scientists First To Identify New Cellular Correlates of Protection Against Influenza for an Oral Flu Vaccine Developed by VaxartGlobeNewsWire • 11/18/21
Earnings Preview: VAXART, INC. (VXRT) Q3 Earnings Expected to DeclineZacks Investment Research • 11/04/21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/04/21
Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical TrialPRNewsWire • 10/26/21